science wire



Results 1 - 50 of 1533.
1 2 3 4 5 ... 31 Next »

Health - Pharmacology - 11.12.2019
Novartis Kisqali data show superior overall survival compared to fulvestrant and consistent efficacy across advanced breast cancer patient subgroups in MONALEESA-3
Patients & Caregivers Healthcare Professionals Society & ESG MONALEESA-3 paper published today in The New England Journal of Medicine shows statistically significant overall survival results

Pharmacology - Health - 09.12.2019
Novartis Kymriah demonstrates consistent efficacy and safety outcomes in US patients when used in real-world setting
Patients & Caregivers Healthcare Professionals Society & ESG Efficacy in DLBCL confirmed results seen in the pivotal trial despite treatment of a broader population, including older and more

Health - Pharmacology - 09.12.2019
Novartis global survey uncovers profound and often under-reported effects on sickle cell disease patients
Patients & Caregivers Healthcare Professionals Society & ESG Findings from more than 2,000 respondents in 16 countries underscore the debilitating and under-reported effects of sickle cell di

Pharmacology - Health - 06.12.2019
Novartis Phase III data on new inhaled dual combination QMF149 show significant improvement across key asthma outcomes versus monotherapy
Patients & Caregivers Healthcare Professionals Society & ESG Once-daily QMF149 met primary endpoint of lung function improvement and key secondary endpoint of asthma control improvement versu

Health - Pharmacology - 03.12.2019

Pharmacology - Health - 02.12.2019
Novartis breadth of data at 2019 ASH demonstrates commitment to reimagining medicine in hematology through innovative therapeutic platforms
Patients & Caregivers Healthcare Professionals Society & ESG With more than 140 abstracts, Novartis continues its leadership in hematology innovation   Data for MBG453, an innovative anti-TIM

Health - Pharmacology - 02.12.2019

Health - Pharmacology - 02.12.2019
Improving Tuberculosis Screening in Remote Areas
Improving Tuberculosis Screening in Remote Areas
Every year, 1.5 million people die from tuberculosis (TB) worldwide. Diagnosis and treatment is particularly difficult in remote rural areas.

Health - Pharmacology - 29.11.2019
In Birmingham could improve outcomes for people at risk of dangerous blood clots
New University of Birmingham research funded by the British Heart Foundation could improve treatments for a potentially deadly condition that affects tens of thousands of people in the UK each year.

Health - Pharmacology - 27.11.2019
Podcast: Vaping concerns, medical detection dogs, and a visit to CERN
In this edition: We explore the possible harms of vaping, meet dogs trained to detect disease, and travel through the physics of CERN.

Health - Pharmacology - 21.11.2019
More than 300 UCLA health care providers treat the homeless at Care Harbor free clinic
For Dr. Patrick Dowling, volunteering at the 2019 Care Harbor free clinic for people who are uninsured or who lack access to health care is a sharp break from his norm of treating people at UCLA Medical Center, Santa Monica.

Pharmacology - Health - 18.11.2019
Wales to lead the way in responsible antibiotics use in veterinary surgeries
The two-year project called Arwain Vet Cymru, is led by the University of Bristol in collaboration with Welsh Lamb and Beef Producers Ltd (WLBP) and Iechyd Da with delivery support from Menter a Busnes and MGC and funded by the Rural Development Programme.

Health - Pharmacology - 18.11.2019
College gets infectious at November's Imperial Lates
College gets infectious at November’s Imperial Lates
From disease roulette to infection-detecting dogs, November's Imperial Lates event explored infections, deadly diseases, and our work to beat them.

Pharmacology - Health - 17.11.2019
Novartis PARAGON-HF analyses suggest Entresto benefit beyond HFrEF
Patients & Caregivers Healthcare Professionals Society & ESG Entresto (sacubitril/valsartan) demonstrated greatest benefit in HFpEF patients with ejection fractions adjacent to HFrEF, compare

Pharmacology - Health - 15.11.2019
New Novartis medicine Adakveo (crizanlizumab) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
Patients & Caregivers Healthcare Professionals Society & ESG Sickle cell pain crises are unpredictable, severe events associated with life-threatening complications 1   Adakveo reduced the an

Pharmacology - Health - 15.11.2019
Novartis receives positive CHMP opinion for Mayzent (siponimod) for the treatment of adult patients with active secondary progressive multiple sclerosis (SPMS)
Patients & Caregivers Healthcare Professionals Society & ESG If approved, Mayzent (siponimod) will be the first and only oral treatment specifically indicated for patients with active seconda

Health - Pharmacology - 14.11.2019
$20 million fundraising effort will support efforts to improve treatment for lung disease
UCLA Health has launched a $20 million fundraising initiative to create a new center for advanced lung disease at the David Geffen School of Medicine at UCLA.

Pharmacology - Health - 14.11.2019
U of M Expert: U.S. Antibiotic Awareness Week
U.S. Antibiotic Awareness Week , which raises awareness of the threat of antibiotic resistance and the importance of appropriate antibiotic use, is November 18-24, 2019. The Centers for

Pharmacology - Health - 12.11.2019
New Novartis PREVENT data show Cosentyx delivers early relief in axial spondyloarthritis
Patients & Caregivers Healthcare Professionals Society & ESG 42.2% of patients with non-radiographic axial spondyloarthritis (nr-axSpA) treated with Cosentyx had improved ASAS40 scores

Health - Pharmacology - 12.11.2019
Sandoz presents real-world data showing effectiveness of Erelzi (etanercept-szzs) in rheumatic disease treatment
Patients & Caregivers Healthcare Professionals Society & ESG Interim results from COMPACT, a multi-country, real-world study of Erelzi for approved rheumatic diseases presented at 2019 ACR/AR

Health - Pharmacology - 11.11.2019
Professor Jonathan Schott named ARUK’s first Chief Medical Officer
National dementia research charity Alzheimer's Research UK (ARUK) has appointed UCL Professor Jonathan Schott as the charity's first ever Chief Medical Officer (CMO).

Health - Pharmacology - 11.11.2019
£2.5 million EU grant to help save NHS patients fighting for life
A new multi-million pound EU-funded research project could help NHS staff provide life-saving treatment to some of the country's most ill patients.

Pharmacology - Health - 11.11.2019
Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone
Roche today announced data from the phase II NOBILITY study, investigating the safety and efficacy of Gazyva (obinutuzumab) for adults with proliferative lupus nephritis.

Pharmacology - Life Sciences - 11.11.2019
Roche’s risdiplam meets primary endpoint in pivotal SUNFISH trial in people with type 2 or 3 spinal muscular atrophy
Roche today announced positive data from the pivotal Part 2 of SUNFISH, a study evaluating risdiplam in people aged 2-25 years with Type 2 or 3 spinal muscular atrophy (SMA).

Health - Pharmacology - 08.11.2019
Birmingham experts join Indian medics to counter surgical infection threat
University of Birmingham experts joined medical professionals in India to lead work in improving care for surgical patients.

Environment - Pharmacology - 08.11.2019
Saving Australia's sea lion population
Saving Australia’s sea lion population
Every sea lion pup in Australia contracts hookworm. Veterinary scientist Rachael Gray and her team are conducting a trial at Seal Bay, Kangaroo Island, with a topical treatment that could help the endangered species' population recover.

Health - Pharmacology - 07.11.2019
German Research Foundation approves new Clinical Research Group
German Research Foundation approves new Clinical Research Group
They are quiet - and in many cases fatal: systemic inflammatory reactions such as sepsis are the third most frequent cause of death in Germany.

Law - Pharmacology - 06.11.2019
Lessons from California’s vaccine exemption laws
California vaccine laws are among the toughest in the nation, particularly since the state did away with the  personal belief and religious exemption  in 2015 following a measles outbreak that began in Disneyland.

Health - Pharmacology - 04.11.2019

Pharmacology - Health - 01.11.2019
Novartis Cosentyx shows encouraging results versus Humira * from first-of-its-kind head-to-head trial in psoriatic arthritis
Cosentyx narrowly missed statistical significance for superiority in ACR 20, the primary endpoint of the EXCEED trial, while showing numerically higher results versus Humira *   Statistically signifi

Health - Pharmacology - 01.11.2019
UQ antibody progresses to clinic with $20m investment
A potential therapy targeting difficult-to-treat immune system disorders such as rheumatoid arthritis will progress to clinical trials next year after securing $20 million in Series A funding.

Health - Pharmacology - 01.11.2019
1 2 3 4 5 ... 31 Next »

This site uses cookies and analysis tools to improve the usability of the site. More information. |